Metraipolis › archive › dc_4949322eed58
Association between immune check point inhibitors and digestive system inflammatory adverse reactions: evidence from pharmacovigilance analysis and systematic… — Europe PMC PMID:41221037
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41221037
- DOI
- 10.3389/fphar.2025.1684475
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T00:55:28.866Z
- SHA-256 of the archived text
f62049bc65c041af22706b3e6db183fa3d76df60f41d6b8c95ce532df6d5f1b4- Stable URL of this page
https://metraipolis.com/documento/dc_4949322eed58
How to cite
Association between immune check point inhibitors and digestive system inflammatory adverse reactions: evidence from pharmacovigilance analysis and systematic… — Europe PMC PMID:41221037 — Europe PMC (en), https://europepmc.org/article/MED/41221037 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4949322eed58 (Metraipolis archive dc_4949322eed58, sha256 f62049bc65c041af22706b3e6db183fa3d76df60f41d6b8c95ce532df6d5f1b4)
BibTeX
@misc{dc4949322eed58,
title = {Association between immune check point inhibitors and digestive system inflammatory adverse reactions: evidence from pharmacovigilance analysis and systematic… — Europe PMC PMID:41221037},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41221037},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4949322eed58; sha256 f62049bc65c041af22706b3e6db183fa3d76df60f41d6b8c95ce532df6d5f1b4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221037. Agents can read the archived copy with the MCP tool read_document.